Categories AlphaGraphs, Earnings, Health Care

VRTX Earnings: A snapshot of Vertex Pharmaceuticals’ Q1 2023 results

Healthcare firm Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported a decline in adjusted earnings for the first quarter, despite an increase in revenues.

Vertex Pharmaceuticals Q1 2023 earnings infographic

Total revenues increased to $2.37 billion in the first quarter from $2.10 billion in the corresponding period of 2022. For the full fiscal year, the management expects product revenues to be between $9.55 billion and $9.70 billion.

Meanwhile, adjusted earnings dropped to $3.05 per share in the March quarter from $3.52 per share in the prior-year period. Unadjusted profit was $699.8 million or $2.69 per share, compared to $762.1 million or $2.96 per share last year.

Prior Performance

  • Vertex-Pharmaceuticals-Q4-2022-Earnings-Infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Delta Air Lines (DAL) Q2 2025 Earnings: Key financials and quarterly highlights

Delta Air Lines (NYSE: DAL) reported its second quarter 2025 earnings results today. Operating revenue remained flat versus the year-ago quarter at $16.64 billion. GAAP net income increased 63% year-over-year

PepsiCo likely to report weak Q2 results as North America demand slumps

After entering fiscal 2025 on a low note, PepsiCo, Inc. (NASDAQ: PEP) is gearing up to publish its second-quarter results. The company is facing sales pressure amid geopolitical tensions and

Bank earnings preview: These banking leaders will report Q2 2025 results next week, what to expect

The earnings season is set to kick off next week with quarterly reports from a number of leading banks. JPMorgan Chase & Co. (NYSE: JPM), Citigroup (NYSE: C) and Wells

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top